BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15627896)

  • 1. The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients.
    Schöndorf T; Eisele L; Göhring UJ; Valter MM; Warm M; Mallmann P; Becker M; Fechteler R; Weisshaar MP; Hoopmann M
    Tumour Biol; 2004; 25(5-6):306-12. PubMed ID: 15627896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
    Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
    Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
    Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
    Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
    J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
    Pasquali D; Circelli L; Faggiano A; Pancione M; Renzullo A; Elisei R; Romei C; Accardo G; Coppola VR; De Palma M; Ferolla P; Grimaldi F; Colao A; Colantuoni V
    Eur J Endocrinol; 2011 Mar; 164(3):397-404. PubMed ID: 21177330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women.
    Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H
    Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the p27/kip1 gene in breast cancer.
    Tigli H; Buyru N; Dalay N
    Mol Diagn; 2005; 9(1):17-21. PubMed ID: 16035731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of PTEN protein and its correlation with p27kip1 and cyclin D1 expression in primary breast cancer].
    Lin Q; Zhuang YZ; Xu DP; Ye JX; Chen PQ
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):246-9. PubMed ID: 12839686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
    Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
    Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
    Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.
    Figueiredo JC; Knight JA; Cho S; Savas S; Onay UV; Briollais L; Goodwin PJ; McLaughlin JR; Andrulis IL; Ozcelik H
    BMC Cancer; 2007 Jun; 7():99. PubMed ID: 17567920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The V109G polymorphism in the p27 gene is associated with endometriosis.
    Camargo-Kosugi CM; da Silva ID; Sato H; D'Amora P; Carvalho CV; Nogueira-de-Souza NC; Girão MJ; Schor E
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):180-3. PubMed ID: 19493606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
    Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.